Millennium Management’s Pyxis Oncology PYXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-16,900
Closed -$62K – 6368
2024
Q3
$62K Buy
+16,900
New +$59.1K ﹤0.01% 5661
2024
Q2
– Sell
-32,000
Closed -$136K – 6405
2024
Q1
$136K Buy
+32,000
New +$135K ﹤0.01% 5498

Other funds holding PYXS

Millennium Management's PYXS Position: Q3 2026 in Review

Millennium Management increased its Pyxis Oncology (PYXS) stake by 257% in Q3 2026, buying an estimated $1.81M and bringing the position to 831,700 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #3943.

Millennium Management first reported a position in PYXS in Q4 2021 and has held it in 17 quarters since. The position peaked at $7M in Q3 2024. 101 funds tracked by Wall St. Rank hold PYXS as of Q3 2026.

  • Millennium Management held 831,700 shares of Pyxis Oncology worth $1.94M as of Q3 2026.
  • Millennium Management bought 598,696 Pyxis Oncology shares in Q3 2026, an estimated $1.81M.
  • Pyxis Oncology made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #3943 holding.
  • Millennium Management first reported a position in Pyxis Oncology in Q4 2021 and has held it in 17 quarters since.
  • Millennium Management's Pyxis Oncology position peaked at $7M in Q3 2024.
  • 101 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2026.

Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.